Phibro Animal Health Corp (FRA:PB8)
€ 23.8 1.8 (8.18%) Market Cap: 952.18 Mil Enterprise Value: 1.35 Bil PE Ratio: 59.42 PB Ratio: 4.00 GF Score: 72/100

Phibro Animal Health Corp at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 10:00PM GMT
Release Date Price: €20.6 (-0.96%)
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

Okay. Good afternoon, everybody. My name is Erin Wright. I cover life sciences tools, diagnostics at Credit Suisse.

We're happy to have Phibro Animal Health with us today. With them, we have CFO, Richard Johnson. Just as a reminder, Phibro is the leading manufacturer of livestock therapeutics across the animal health space, where we cover a bunch of different companies.

I guess I wanted to kick off -- and this is a fireside chat, so feel free to reach out or raise your hand if you do have a question or e-mail me if you would also like to submit a question for me to ask. I'm happy to do so.

I'll start off and kick it off kind of the most recent quarter. Can you give us an overview of the more recent trends you're seeing, an update on ASF and global dynamics across your different livestock segments?

Richard G. Johnson
Phibro Animal Health Corporation - CFO

Our most recent September quarter

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot